108 related articles for article (PubMed ID: 5034813)
41. Antibiotics produced by mutants of Streptomyces caelestis. II. N-demethylcelesticetin and N-demethyl-7-O-demethylcelesticetin.
Argoudelis AD; Coats JH; Lemaux PG; Sebek OK
J Antibiot (Tokyo); 1973 Jan; 26(1):7-14. PubMed ID: 4781281
[No Abstract] [Full Text] [Related]
42. Inhibitors of N(alpha)-acetyl-L-ornithine deacetylase: synthesis, characterization and analysis of their inhibitory potency.
Hlavácek J; Pícha J; Vanek V; Jirácek J; Slaninová J; Fucík V; Budĕsínský M; Gilner D; Holz RC
Amino Acids; 2010 Apr; 38(4):1155-64. PubMed ID: 19649769
[TBL] [Abstract][Full Text] [Related]
43. Eurystatins A and B, new prolyl endopeptidase inhibitors. III. Fermentation and controlled biosynthesis of eurystatin analogs by Streptomyces eurythermus.
Suzuki K; Toda S; Furumai T; Fukagawa Y; Oki T
J Antibiot (Tokyo); 1994 Sep; 47(9):982-91. PubMed ID: 7928700
[TBL] [Abstract][Full Text] [Related]
44. Metabolic products of microorganisms. 255. Nikkomycins Wz and Wx, new chitin synthetase inhibitors from Streptomyces tendae.
Decker H; Walz F; Bormann C; Zähner H; Fiedler HP; Heitsch H; König WA
J Antibiot (Tokyo); 1990 Jan; 43(1):43-8. PubMed ID: 2137814
[TBL] [Abstract][Full Text] [Related]
45. Identification of 5-fluoro-5-deoxy-D-ribose-1-phosphate as an intermediate in fluorometabolite biosynthesis in Streptomyces cattleya.
Cobb SL; Deng H; Hamilton JT; McGlinchey RP; O'Hagan D
Chem Commun (Camb); 2004 Mar; (5):592-3. PubMed ID: 14973623
[TBL] [Abstract][Full Text] [Related]
46. New amino acids from Streptomyces.
Argoudelis AD; Herr RR; Mason DJ; Pyke TR; Zieserl JF
Biochemistry; 1967 Jan; 6(1):165-70. PubMed ID: 6030314
[No Abstract] [Full Text] [Related]
47. A practicable variant of the ion exchange method for the radiometric estimation of ornithine decarboxylase activity.
Weber LW
Experientia; 1987 Feb; 43(2):176-8. PubMed ID: 3545892
[TBL] [Abstract][Full Text] [Related]
48. Antibiotic A-16316-C, a new water-soluble basic antibiotic.
Tamura A; Furuta R; Kotani H
J Antibiot (Tokyo); 1975 Apr; 28(4):260-5. PubMed ID: 1097383
[TBL] [Abstract][Full Text] [Related]
49. In vivo and enzymatic conversion of toyocamycin to sangivamycin by Streptomyces rimosus.
Uematsu T; Suhadolnik RJ
Arch Biochem Biophys; 1974 Jun; 162(2):614-9. PubMed ID: 4407150
[No Abstract] [Full Text] [Related]
50. GE20372 factor A and B. New HIV-1 protease inhibitors, produced by Streptomyces sp. ATCC 55925.
Stefanelli S; Cavaletti L; Sarubbi E; Ragg E; Colombo L; Selva E
J Antibiot (Tokyo); 1995 Apr; 48(4):332-4. PubMed ID: 7775273
[No Abstract] [Full Text] [Related]
51. New tylosin analogs produced by mutants of Streptomyces fradiae.
Kiyoshima K; Takada K; Yamamoto M; Kubo K; Okamoto R; Fukagawa Y; Ishikura T; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1987 Aug; 40(8):1123-30. PubMed ID: 3680024
[TBL] [Abstract][Full Text] [Related]
52. Absolute stereochemistry determination of 16-methyloxazolomycin produced by a Streptomyces sp.
Ryu G; Kim SK
J Antibiot (Tokyo); 1999 Feb; 52(2):193-7. PubMed ID: 10344577
[No Abstract] [Full Text] [Related]
53. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.
McCall TB; Feelisch M; Palmer RM; Moncada S
Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525
[TBL] [Abstract][Full Text] [Related]
54. FK-506 related compounds produced by Streptomyces tsukubaensis No. 9993.
Hatanaka H; Kino T; Asano M; Goto T; Tanaka H; Okuhara M
J Antibiot (Tokyo); 1989 Apr; 42(4):620-2. PubMed ID: 2470720
[No Abstract] [Full Text] [Related]
55. Microbial transformations and 13C-NMR analysis of colchicine.
Hufford CD; Collins CC; Clark AM
J Pharm Sci; 1979 Oct; 68(10):1239-43. PubMed ID: 512852
[TBL] [Abstract][Full Text] [Related]
56. New seco-milbemycins from Streptomyces bingchenggensis: fermentation, isolation and structure elucidation.
Xiang WS; Wang JD; Fan HM; Wang XJ; Zhang J
J Antibiot (Tokyo); 2008 Jan; 61(1):27-32. PubMed ID: 18305356
[TBL] [Abstract][Full Text] [Related]
57. 7-Hydroxyguanine, a novel antimetabolite from a strain of Streptomyces purpurascens. I. Taxonomy of producing organism, fermentation, isolation and biological activity.
Kitahara M; Ishii K; Kumada Y; Shiraishi T; Furuta T; Miwa T; Kawaharada H; Watanabe K
J Antibiot (Tokyo); 1985 Aug; 38(8):972-6. PubMed ID: 3840157
[TBL] [Abstract][Full Text] [Related]
58. 4-chlorothreonine, a herbicidal antimetabolite produced by Streptomyces sp. OH-5093.
Yoshida H; Arai N; Sugoh M; Iwabuchi J; Shiomi K; Shinose M; Tanaka Y; Omura S
J Antibiot (Tokyo); 1994 Oct; 47(10):1165-6. PubMed ID: 7961168
[No Abstract] [Full Text] [Related]
59. 3-Amino-5-hydroxybenzoic acid in antibiotic biosynthesis. VI. Directed biosynthesis studies with ansamycin antibiotics.
Becker AM; Herlt AJ; Hilton GL; Kibby JJ; Rickards RW
J Antibiot (Tokyo); 1983 Oct; 36(10):1323-8. PubMed ID: 6643281
[TBL] [Abstract][Full Text] [Related]
60. New metabolites, tetrahydrofuran lignans, produced by Streptomyces sp. IT-44.
Chiung YM; Hayashi H; Matsumoto H; Otani T; Yoshida K; Huang MY; Chen RX; Liu JR; Nakayama M
J Antibiot (Tokyo); 1994 Apr; 47(4):487-91. PubMed ID: 8195049
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
